Prad Sekar on Leveraging Data to Bring Medical Cannabis to the Masses | #HashtagFinance

CB2 Insight's (CSE:CBII) CEO Pradyum Sekar recently sat down with Barrington Miller to discuss the importance of medically validated cannabis data (3:45), the challenge of breaking down barriers with physicians (9:45), and the impact of big pharma on medical cannabis (13:30). Listen until the end to hear about Prad's experience around launching the company, pivoting the business (hint - vertical integration!), and their recent launch on the CSE - Canadian Securities Exchange.🔴  Subscribe for more great CSE insights and interviews here: https://go.thecse.com/CSETV-Subscribe#AlwaysInvestedSTAY CONNECTED WITH THE CSE =============================📧 - NEWSLETTER: https://go.thecse.com/CSE-Mailing-List-Subscribe🎧 - PODCAST: https://blog.thecse.com/cse-podcasts/📸 - INSTAGRAM: https://www.instagram.com/canadianexchange/🤝 - LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange👥 - FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/🐦 - X: https://x.com/CSE_News📝 - BLOG: https://blog.thecse.com/🖥 - WEBSITE: https://thecse.com/📖 - MAGAZINE: https://issuu.com/thecse/docs©2026 CNSX Markets Inc. All rights reserved.